Large-scale testing (Phase 3)Study completedNCT00003367What this trial is testingDiet and PSA Levels in Patients With Prostate CancerWho this might be right forProstate Cancer Memorial Sloan Kettering Cancer Center 154
Testing effectiveness (Phase 2)Ended earlyNCT04423913What this trial is testingSafety, Tolerability, Distribution & Dose Effect of Neoadjuvant Transarterial Chemoembolization With Doxorubicin in Prostate Cancer Patients Before Radical ProstatectomyWho this might be right forProstate Cancer Centre Hospitalier Universitaire de Nīmes 12
Not applicableStudy completedNCT01542021What this trial is testingAndrogen Deprivation Therapy Prior to Prostatectomy for Patients With Intermediate and High Risk Prostate CancerWho this might be right forProstate CancerProstatic Adenocarcinoma Memorial Sloan Kettering Cancer Center 41
Testing effectiveness (Phase 2)Study completedNCT03643107What this trial is testingIrofulven in AR-targeted and Docetaxel-Pretreated mCRPC Patients With Drug Response Predictor (DRP®)Who this might be right forMetastatic Castration-Resistant Prostate Cancer Patients Allarity Therapeutics 15
Large-scale testing (Phase 3)UnknownNCT00175396What this trial is testingAndrogen Suppression Combined With Elective Nodal and Dose Escalated Radiation TherapyWho this might be right forProstate Cancer University of British Columbia 400
Large-scale testing (Phase 3)Study completedNCT00002703What this trial is testingRadiation Therapy in Treating Patients With Stage I or Stage II Prostate CancerWho this might be right forProstate Cancer Proton Radiation Oncology Group 390
Testing effectiveness (Phase 2)Looking for participantsNCT04700332What this trial is testingPyL in Patients With High Risk and Biochemically Recurrent Prostate CancerWho this might be right forProstate Cancer Hoag Memorial Hospital Presbyterian 184
Large-scale testing (Phase 3)Study completedNCT01546987What this trial is testingHormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate CancerWho this might be right forProstate Cancer Radiation Therapy Oncology Group 239
Large-scale testing (Phase 3)Looking for participantsNCT05448547What this trial is testingImmediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate CancerWho this might be right forProstate Cancer Sven Löffeler 980
Not applicableStudy completedNCT00898274What this trial is testingStudy of Blood Samples From Older Patients at High Risk of Developing Prostate Cancer and From Healthy Male ParticipantsWho this might be right forPrecancerous ConditionProstate Cancer Case Comprehensive Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT03518606What this trial is testingMetronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid TumoursWho this might be right forAdvanced Solid TumoursBreast CancerHead and Neck Cancer+2 more UNICANCER 126
Not applicableActive Not RecruitingNCT05361902What this trial is testingA First Step Towards Ultra-hypofractionation for Unfavourable Intermediate and High-risk Prostate CancerWho this might be right forProstate Cancer Erasmus Medical Center 35
Early research (Phase 1)WithdrawnNCT00691977What this trial is testingRadiation Therapy Followed by Surgery in High-Risk, Localized Carcinoma of the ProstateWho this might be right forProstate Cancer Virginia Commonwealth University
Not applicableLooking for participantsNCT07219303What this trial is testingAdaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate CancerWho this might be right forProstate Cancer (Adenocarcinoma) Fox Chase Cancer Center 80
Large-scale testing (Phase 3)Looking for participantsNCT06952803What this trial is testingMetastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA MutationWho this might be right forProstate Cancer AstraZeneca 700
Testing effectiveness (Phase 2)Study completedNCT00551525What this trial is testingSamarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate CancerWho this might be right forProstate Cancer Radiation Therapy Oncology Group 67
Not applicableLooking for participantsNCT04894188What this trial is testingNeoadjuvant Hormone and Radiation Therapy Followed by Radical Prostatectomy in Patients With High-Risk Prostate CancerWho this might be right forProstate Cancer National Taiwan University Hospital 38
Testing effectiveness (Phase 2)Active Not RecruitingNCT03637543What this trial is testingNivolumab in Patients With High-Risk Biochemically Recurrent Prostate CancerWho this might be right forProstate Cancer Beth Israel Deaconess Medical Center 29
Testing effectiveness (Phase 2)Study completedNCT03113617What this trial is testing68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate CancerWho this might be right forStage II Prostate AdenocarcinomaStage III Prostate AdenocarcinomaStage IV Prostate Adenocarcinoma Andrei Iagaru 44
Not applicableUnknownNCT00392535What this trial is testingIntensity-Modulated Radiation Therapy in Treating Patients With Localized Prostate CancerWho this might be right forProstate Cancer Institute of Cancer Research, United Kingdom 3,216